Taiwo Abimbola
Overview
Explore the profile of Taiwo Abimbola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wallace A, Date K, Pallas S, Wongjindanon N, Phares C, Abimbola T
Vaccines (Basel)
. 2024 Nov;
12(11).
PMID: 39591138
Oral cholera vaccination (OCV) campaigns are increasingly used to prevent cholera outbreaks; however, little is known about their cost-effectiveness in refugee camps. We conducted a cost-effectiveness analysis of a pre-emptive...
2.
Biya O, Archer W, Rayner J, Welwean R, Jegede A, Jacenko S, et al.
Pan Afr Med J
. 2022 Sep;
40(Suppl 1):1.
PMID: 36157560
Introduction: In July 2012, the National Stop Transmission of Polio (NSTOP) program was established to support the Government of Nigeria in interrupting transmission of poliovirus and strengthen routine immunization (RI)....
3.
Hidle A, Brennan T, Garon J, An Q, Loharikar A, Marembo J, et al.
Vaccine
. 2022 Feb;
40 Suppl 1:A67-A76.
PMID: 35181152
Background: After a pilot project in 2014-15 Zimbabwe introduced the human papillomavirus (HPV) vaccine nationally in 2018 for girls aged 10-14 years through a primarily school-based vaccination campaign with two...
4.
Brennan T, Hidle A, Doshi R, An Q, Loharikar A, Casey R, et al.
Vaccine
. 2021 Dec;
40 Suppl 1:A77-A84.
PMID: 34955325
Introduction: In 2018, Senegal introduced human papillomavirus (HPV) vaccine into its routine immunization program for all nine-year-old girls nationwide. We evaluated the costs of Senegal's introduction of HPV vaccine via...
5.
Ozawa S, Yemeke T, Mitgang E, Wedlock P, Higgins C, Chen H, et al.
Vaccine
. 2021 Jul;
39(33):4598-4610.
PMID: 34238610
Introduction: Economic evidence on how much it may cost for vaccinators to reach populations is important to plan vaccination programs. Moreover, knowing the incremental costs to reach populations that have...
6.
Yemeke T, Mitgang E, Wedlock P, Higgins C, Chen H, Pallas S, et al.
Vaccine
. 2021 Jul;
39(32):4437-4449.
PMID: 34218959
Introduction: Understanding the costs to increase vaccination demand among under-vaccinated populations, as well as costs incurred by beneficiaries and caregivers for reaching vaccination sites, is essential to improving vaccination coverage....
7.
Cox S, Wedlock P, Pallas S, Mitgang E, Yemeke T, Bartsch S, et al.
Vaccine
. 2021 May;
39(46):6796-6804.
PMID: 34045101
Background: Understanding the economics of vaccination is essential to developing immunization strategies that can be employed successfully with limited resources, especially when vaccinating populations that are hard-to-reach. Methods: Based on...
8.
Mejia N, Qamar F, Yousafzai M, Raza J, Garrett D, Date K, et al.
Clin Infect Dis
. 2020 Dec;
71(Suppl 3):S319-S335.
PMID: 33258941
Background: The objective of this study was to estimate the cost of illness from enteric fever (typhoid and paratyphoid) at selected sites in Pakistan. Methods: We implemented a cost-of-illness study...
9.
Mejia N, Pallas S, Saha S, Udin J, Sayeed K, Garrett D, et al.
Clin Infect Dis
. 2020 Dec;
71(Suppl 3):S293-S305.
PMID: 33258940
Background: We conducted a cost of illness study to assess the economic burden of pediatric enteric fever (typhoid and paratyphoid) in Bangladesh. Results can inform public health policies to prevent...
10.
Mejia N, Abimbola T, Andrews J, Vaidya K, Tamrakar D, Pradhan S, et al.
Clin Infect Dis
. 2020 Dec;
71(Suppl 3):S306-S318.
PMID: 33258938
Background: Enteric fever is endemic in Nepal and its economic burden is unknown. The objective of this study was to estimate the cost of illness due to enteric fever (typhoid...